Physician profile
George B Inge
NPI 1255363537
$816.46
in general payments reported to CMS, 2019-2025
12 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $61.13 · 2021: $72.76 · 2022: $68.58 · 2023: $51.17 · 2024: $205 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $299.31 | 2024-2025 | Origio Sequential Fert, Stripper |
| Ferring Pharmaceuticals INC. | $146.25 | 2019-2023 | Menopur |
| Abbvie INC. | $114.94 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $65.91 | 2023-2024 | Myfembree |
| Organon LLC | $44.71 | 2022-2025 | Ganirelix Acetate, Follistim Aq, Pregnyl |
| Meditrina | $31.44 | 2022 | |
| Baxter Healthcare | $27.05 | 2020 | |
| Emd Serono, INC. | $22.90 | 2019 | |
| Merck Sharp & Dohme LLC | $19.77 | 2020 | |
| Duchesnay USA Incorporated | $16.97 | 2019 | |
| Myovant Sciences INC. | $14.54 | 2021 | |
| Hologic Sales and Service, LLC | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Inge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.